Neurocrine Biosciences | 流动资产

Current Assets 更改 日
AbbVie USD 38.87B 5.65B 2024-03
Acadia Pharmaceuticals USD 675.3M 59.17M 2024-03
Agios Pharmaceuticals USD 663.63M 170.21M 2024-03
ALKERMES USD 1.47B 37.69M 2024-03
Alnylam Pharmaceuticals USD 2.99B 5.91M 2024-03
Amgen USD 28.03B 2.3B 2024-03
Biogen USD 6.76B 103.1M 2024-03
BioMarin Pharmaceutical USD 2.99B 28.92M 2024-03
Cytokinetics USD 638.7M 10.65M 2024-03
Dynavax Technologies USD 851.29M 7.83M 2024-03
Exelixis USD 1.29B 150.94M 2024-03
Gilead Sciences USD 14.04B 2.41B 2024-03
Halozyme Therapeutics USD 873.58M 127.16M 2024-03
Incyte USD 4.85B 203.69M 2024-03
Intra Cellular Therapies USD 690.53M 22.73M 2024-03
Ionis Pharmaceuticals USD 2.42B 226.18M 2024-03
Neurocrine Biosciences USD 1.8B 149.1M 2024-03
Pfizer USD 42.42B 31.6B 2024-03
Prothena USD 565.87M 73.41M 2024-03
Regeneron Pharmaceuticals USD 18.87B 5.62B 2024-03
Repligen USD 1.13B 154.56M 2024-03
Sarepta Therapeutics USD 2.46B 14.02M 2024-03
Teva Pharmaceutical Industries USD 12.3B 188M 2024-03
Ultragenyx Pharmaceutical USD 595.97M 3.22M 2024-03
Vertex Pharmaceuticals USD 13.29B 1.41B 2024-03



Neurocrine Biosciences 流动资产 - 当前值，历史数据，预测，统计，图表和经济日历 - Jun 2024.